Cyclin D2 expression in familial and sporadic breast cancer

Oncology Reports

Volumn 9, Issue 6, 2002, Pages 1157-1161

  Fischer, Heléne ^a   Chen, Jindong ^b   Skoog, Lambert ^c   Lindblom, Annika ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Breast cancer; Cyclin D2; Differential display; Methylation

Indexed keywords

AZACITIDINE; CCND2 PROTEIN, HUMAN; CYCLINE; DNA; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; PRIMER DNA;

ARTICLE; BREAST; BREAST TUMOR; CELL CULTURE; CHEMISTRY; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

AZACITIDINE; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BREAST; BREAST NEOPLASMS; CYCLINS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, NEOPLASM; DOWN-REGULATION; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036834327     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.6.1157     Document Type: Article

References (27)

1. Arver B, Du Q, Chen J, Luo L and Lindblom A: Hereditary breast cancer: a review. Semin Cancer Biol 10: 271-288, 2000.
2. Lapidus RG, Nass SJ and Davidson NE: The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mammary Gland Biol Neoplasia 3: 85-94, 1998. (Pubitemid 128513222)
3. Salahshor S, Haixin L, Huo H, Kristensen VN, Loman N, Sjoberg-Margolin S, Borg A, Borresen-Dale AL, Vorechovsky I and Lindblom A: Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res 3: 199-207, 2001. (Pubitemid 32390221)
4. Slamon DJ and Clark GM: Amplification of c-erbB-2 and aggressive human breast tumors? Science 240: 1795-1798, 1988.
5. Hunter T and Pines J: Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994. (Pubitemid 24363801)
6. Motokura T and Arnold A: Cyclins and oncogenesis. Biochim Biophys Acta 1155: 63-78, 1993. (Pubitemid 23163751)
7. Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, Di Renzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M and Ewen ME: Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 17: 5338-5347, 1997. (Pubitemid 27357632)
8. Zhang P: The cell cycle and development: redundant roles of cell cycle regulators. Curr Opin Cell Biol 11: 655-662, 1999.
9. Baldin V, Lukas J, Marcote MJ, Pagano M and Draetta G: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7: 812-821, 1993. (Pubitemid 23163585)
10. Won KA, Xiong Y, Beach D and Gilman MZ: Growth regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sei USA 89: 9910-9914, 1992.
11. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, De Fazio A, Watts CK, Musgrove EA and Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133, 1993. (Pubitemid 23226946)
12. Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J and Sukumar S: Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res 61: 2782-2787, 2001. (Pubitemid 32685869)
13. Lukas J, Bartkova J, Welcker M, Petersen OW, Peters G, Strauss M and Bartek J: Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene 10: 2125-2134, 1995.
14. Liang P and Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-971, 1992.
15. Liang P and Pardee AB: Recent advances in differential display. Curr Opin Immunol 7: 274-280, 1995.
16. Sambrook J, Fritsch EF and Maniatis Y: Molecular Cloning: A laboratory Manual. Vol. 2nd edition. Cold Spring Harbor Laboratory Press, 1989.
17. Brooks AR, Shiffman D, Chan CS, Brooks EE and Milner PG: Functional analysis of the human cyclin D2 and cyclin D3 promoters. J Biol Chem 271: 9090-9099, 1996. (Pubitemid 26123342)
18. Vercoutter-Edouart A, Lemoine J, Smart CE, Nurcombe V, Boilly B, Peyrat J and Hondermarck H: The mitogenic signaling pathway for fibroblast growth factor-2 involves the tyrosine phosphorylation of cyclin D2 in MCF-7 human breast cancer cells. FEBS Lett 478: 209-215, 2000. (Pubitemid 30621619)
19. Delehedde M, Boilly B and Hondermarck H: Differential responsiveness of human breast cancer cells to basic fibroblast growth factor: a cell kinetics study. Oncol Res 7: 399-405, 1995.
20. Takano Y, Kato Y, Masuda M, Ohshima Y and Okayasu I: Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis. J Pathol 189: 194-200, 1999. (Pubitemid 29448912)
21. Takano Y, Kato Y, van Diest PJ, Masuda M, Mitomi H and Okayasu I: Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 156: 585-594, 2000. (Pubitemid 30643814)
22. Alle KM, Henshall SM, Field AS and Sutherland RL: Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin Cancer Res 4: 847-854, 1998. (Pubitemid 28183384)
23. Courjal F, Louason G, Speiser P, Katsaros D, Zeillinger R and Theillet C: Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int J Cancer 69: 247-253, 1996. (Pubitemid 26298285)
24. Steeg PS and Zhou Q: Cyclins and breast cancer. Breast Cancer Res Treat 52: 17-28, 1998. (Pubitemid 29056082)
25. Sweeney KJ, Sarcevic B, Sutherland RL and Musgrove EA: Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells. Oncogene 14: 1329-1340, 1997. (Pubitemid 27151990)
26. Fenig E, Wieder R, Paglin S, Wang H, Persaud R, Haimovitz-Friedman A, Fuks Z and Yahalom J: Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells. Clin Cancer Res 3: 135-142, 1997. (Pubitemid 27079456)
27. Johnson MR, Valentine C, Basilico C and Mansukhani A: FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells. Oncogene 16: 2647-2656, 1998. (Pubitemid 28264042)